Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC class I and II expression in breast cancer patients - PubMed (original) (raw)

Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC class I and II expression in breast cancer patients

P Whitford et al. Cancer Lett. 1992.

Abstract

The primary tumour cells and tumour infiltrating lymphocytes (TILs) of 31 breast cancer patients have been analysed by dual colour flow cytometry to determine whether the phenotype and/or activation status of the TILs bears any relationship to the expression of MHC antigens on the tumour cells. The phenotype and activation status of 5000 TILs were studied using Mabs to CD4, CD8, HLA DR, CD25 (the low affinity inducible IL-2 receptor) and the transferrin receptor and related to Class I and Class II MHC expression on 5000 primary tumour cells. On the tumour cells, Class I MHC expression ranged from 1-74%, averaging 12.9%. HLA DR expression ranged from 1-69% averaging 14.3%. When the phenotypic proportions of the lymphocytic infiltrate were analysed there was found to be a correlation between tumour expression of Class I MHC and the proportion of both CD4+ (P less than 0.05) and CD8+ (P less than 0.02) T cells within the tumour. No such relationship was found with the MHC Class II antigen. When TIL activation markers were analysed, the percentage of CD8+ TILs positive for HLA DR expression correlated strongly with the expression of Class I (P less than 0.001) and Class II (P less than 0.001) antigens on the tumour cells. The percentage of CD4+ TILs positive for HLA DR expression also correlated significantly, but less strongly with the expression of Class I (P less than 0.01) and Class II (P less than 0.02) antigen expression on the tumour cells. The percentage of CD4+ TILs positive for CD25 expression correlated with both Class I (P less than 0.05) and Class II (P less than 0.03) expression on the tumour cells while the percentage of CD8+ TILs positive for CD25 did not. The percentage of TILs bearing the transferrin receptor showed no measurable correlation with the expression of either class of MHC antigen on the tumour. The data suggest that MHC expression on the tumour cells has a selective effect on the response capacity of different parts of the immune system.

PubMed Disclaimer

Cited by

Triple-Negative Breast Cancer Intrinsic FTSJ1 Favors Tumor Progression and Attenuates CD8+ T Cell Infiltration.
Sun Y, Liu Q, Zhong S, Wei R, Luo JL. Sun Y, et al. Cancers (Basel). 2024 Jan 31;16(3):597. doi: 10.3390/cancers16030597. Cancers (Basel). 2024. PMID: 38339348 Free PMC article.
Immunohistochemical study of the expressed cluster differentiation markers proteins type 20 and 56 in breast tissues from a group of Iraqi patients with breast cancers.
Zeiny SMH, Mohammed Ali SH. Zeiny SMH, et al. Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3621-3628. doi: 10.31557/APJCP.2023.24.10.3621. Asian Pac J Cancer Prev. 2023. PMID: 37898871 Free PMC article.
Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer.
Luque M, Sanz-Álvarez M, Morales-Gallego M, Madoz-Gúrpide J, Zazo S, Domínguez C, Cazorla A, Izarzugaza Y, Arranz JL, Cristóbal I, Rojo F. Luque M, et al. Cancers (Basel). 2022 Dec 8;14(24):6034. doi: 10.3390/cancers14246034. Cancers (Basel). 2022. PMID: 36551522 Free PMC article. Review.
Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer.
Su GH, Xiao Y, Jiang L, Zheng RC, Wang H, Chen Y, Gu YJ, You C, Shao ZM. Su GH, et al. J Transl Med. 2022 Oct 15;20(1):471. doi: 10.1186/s12967-022-03688-x. J Transl Med. 2022. PMID: 36243806 Free PMC article.

Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC class I and II expression in breast cancer patients - PubMed (original) (raw)